Company: CRNX
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057452
Chunk: 10

Company: Crinetics Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 10
---
 cast. This means that the three nominees receiving the highest number of affirmative “FOR” votes will be elected as Class I directors. | Votes withheld and broker non-votes will have no effect.                                 |
| Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm        | The affirmative vote of a majority of the votes cast for or against the matter.                                                                                   | Abstentions will have no effect. We do not expect any broker non-votes on this proposal. |
| Proposal 3: Approval, on an advisory basis, of the Compensation of the Named Executive Officers | The affirmative vote of a majority of the votes cast for or against the matter.                                                                                   | Abstentions and broker non-votes will have no effect.                                    |

Could other matters be decided at the annual meeting? Our bylaws require that we receive advance notice of any proposal to be brought before the annual meeting by stockholders. As of the date of this proxy statement, there are no other matters that our board of directors intends to present for action at the annual meeting other than those referred to in this proxy statement. If any other matter were to come before the annual meeting, the proxy holders appointed by our board of directors will have the discretion to vote on those matters for you. Is my vote confidential? Proxy instructions, ballots and voting tabulations that identify individual stockholders are handled in a manner that protects your voting privacy. Your vote will not be disclosed either within our company or to third parties, except: (1) as necessary for applicable legal requirements, (2) to allow for the tabulation and certification of the votes and (3) to facilitate a successful proxy solicitation. Occasionally, stockholders provide written comments on their proxy cards, which may be forwarded to our management. Who is paying the costs of soliciting these proxies? We will pay all of the costs of soliciting these proxies. Our directors, officers and other employees may solicit proxies in person or by mail, telephone, fax or email. We will not pay our directors, officers and other employees any additional compensation for these services. We will ask banks, brokers and other institutions, nominees and fiduciaries to forward these proxy materials to their principals and to obtain authority to execute proxies. We will then reimburse them for their expenses. Our costs for forwarding proxy materials will not be significant. We intend to file a proxy statement and proxy card with the SEC in connection with its solicitation of proxies for our 2025 annual meeting. Stockholders may obtain our proxy statement (